Seres therapeutics to participate in the 42nd annual j.p. morgan healthcare conference

Cambridge, mass.--(business wire)--seres therapeutics, inc. (nasdaq: mcrb), a leading microbiome therapeutics company, today announced that seres management will present at the 42nd annual j.p. morgan healthcare conference in san francisco, ca on wednesday, january 10, 2024, at 12:45 p.m. et / 9:45 am pt. an audio webcast of the presentation will be available under the “investors and news” section of seres' website. a replay of the presentation will become available approximately one hour after.
MCRB Ratings Summary
MCRB Quant Ranking